Scarica l'app Stockscreener
39.20
2.05%
-0.82
Dopo l'orario di chiusura:
39.25
0.05
+0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Precedente Chiudi:
$40.02
Aprire:
$40
Volume 24 ore:
22.13M
Relative Volume:
0.81
Capitalizzazione di mercato:
$8.92B
Reddito:
$1.78B
Utile/perdita netta:
$164.40M
Rapporto P/E:
56.81
EPS:
0.69
Flusso di cassa netto:
$236.51M
1 W Prestazione:
-1.41%
1M Prestazione:
-10.36%
6M Prestazione:
-25.72%
1 anno Prestazione:
+24.05%
Intervallo 1D:
$39.17
$40.99
Intervallo di 1 settimana:
$35.78
$40.99
Portata 52W:
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Nome
Hims Hers Health Inc
Settore
Telefono
415-851-0195
Indirizzo
2269 CHESTNUT ST, SAN FRANCISCO
Confronta HIMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
39.20 | 9.11B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
118.65 | 53.06B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.18 | 45.11B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.44B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.46 | 32.59B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
489.31 | 20.84B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | Downgrade | Needham | Buy → Hold |
| 2025-06-04 | Reiterato | Needham | Buy |
| 2025-04-29 | Downgrade | TD Cowen | Buy → Hold |
| 2025-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Downgrade | Citigroup | Neutral → Sell |
| 2025-01-07 | Iniziato | BTIG Research | Buy |
| 2024-12-17 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-08-22 | Iniziato | Needham | Buy |
| 2024-08-09 | Downgrade | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-04-16 | Downgrade | Jefferies | Buy → Hold |
| 2024-04-10 | Iniziato | Canaccord Genuity | Buy |
| 2024-02-28 | Aggiornamento | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | Imperial Capital | In-line |
| 2023-07-28 | Iniziato | TD Cowen | Outperform |
| 2023-04-11 | Iniziato | Robert W. Baird | Neutral |
| 2023-02-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-08 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-07-15 | Iniziato | SVB Leerink | Underperform |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-10 | Iniziato | Deutsche Bank | Hold |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-11-11 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Iniziato | BofA Securities | Neutral |
| 2021-05-20 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Iniziato | Truist | Hold |
| 2021-03-09 | Iniziato | Credit Suisse | Neutral |
| 2021-03-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Iniziato | Citigroup | Neutral |
| 2021-02-12 | Iniziato | Piper Sandler | Neutral |
| 2021-02-08 | Iniziato | Tigress Financial | Buy |
Mostra tutto
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Hims & Hers Health, Inc. $HIMS Stake Lowered by State Board of Administration of Florida Retirement System - MarketBeat
Clear Street LLC Invests $83.58 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
HIMS HERS HEALTH INC - Financial Post
Hims and Hers acquires Livewell ahead of generic Ozempic launch in Canada - Financial Post
Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves - TradingView
Hims & Hers Continues Major International Expansion With Officia - GuruFocus
Leerink Partnrs Upgrades Hims & Hers Health (NYSE:HIMS) to Strong-Buy - MarketBeat
2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm - Finviz
Norges Bank Makes New $78.46 Million Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat
A New Market, A New Catalyst: Assessing Hims & Hers' Canadian Opportunity (NYSE:HIMS) - Seeking Alpha
American Century Companies Inc. Buys 42,510 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Notable Thursday Option Activity: HIMS, GAP, BE - Nasdaq
Hims & Hers Health, Inc. acquired Livewell. - marketscreener.com
Hims & Hers Snaps Up YourBio To Bring Pain-Free Blood Tests Home - Sahm
Hims & Hers propose désormais ses services aux clients du Canada - Hastings Tribune
Hims & Hers expands into diagnostics, moves into Canada as it evolves DTC telehealth platform - Fierce Healthcare
HIMS Stock Jumps After Buyout Deal, Boosts Blood Collection Efficiency - TradingView
Hims & Hers Targets Canadian Obesity Crisis in Bold Weight-Loss Push with Semaglutide Tailwind - Yahoo Finance
What's Going On With Shares Of Hims & Hers Health Thursday? - Benzinga
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Finviz
Leerink Partners lowers Hims and Hers stock price target on increased investment costs By Investing.com - Investing.com
Market movers: Meta, Hims and Hers, Dollar General, Gunnison Copper… - Proactive financial news
Hims & Hers Health (HIMS) Expands into Canada with Livewell Acqu - GuruFocus
Hims & Hers Health stock rises after Canadian market entry By Investing.com - Investing.com UK
Schroder Investment Management Group Has $20.57 Million Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health Acquires Livewell, Officially Enters Canadian Market - marketscreener.com
Hims & Hers expands into Canadian market following Livewell acquisition - Investing.com India
Hims & Hers shares jump on expansion into Canada - Proactive financial news
Hims & Hers expands into Canadian market following Livewell acquisition By Investing.com - Investing.com UK
Hims & Hers Now Serving Customers in Canada - Hims Investor Relations
Hims & Hers Continues Major International Expansion With Official Entry Into Canada - The Joplin Globe
Hims & Hers Continues Major International Expansion with Official Entry into Canada - Hims & Hers Newsroom
Hims & Hers acquires Livewell in Canada in anticipation of generic Ozempic - The Globe and Mail
What Hims & Hers Health (HIMS)'s Margin Squeeze, Buyback and YourBio Deal Mean For Shareholders - Yahoo Finance
Hims & Hers Health signs agreement to acquire YourBio Health - Yahoo Finance
Hims & Hers Stock Gains on Move Into Canada - The Wall Street Journal
Hims & Hers to acquire blood sampling tech company - Modern Healthcare
Hims & Hers Health (HIMS) Down 15.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Hims & Hers Expands Care Scope as Prescription Platforms Evolve - Yahoo Finance
Hims & Hers to acquire YourBio Health, pioneer behind advanced, pain-free blood sampling technology - marketscreener.com
Hims & Hers Health (HIMS) to Acquire YourBio Health for Tech Exp - GuruFocus
Hims & Hers to buy YourBio Health for blood sampling technology (HIMS:NYSE) - Seeking Alpha
Hims & Hers to acquire YourBio Health for painless blood sampling tech - Investing.com
Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology - Hims Investor Relations
Hims & Hers Health (HIMS): Evaluating Valuation After Recent Share Price Drop - Yahoo Finance
Hims & Hers Health and F5 have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
GraniteShares Expands YieldBOOST™ Lineup with Two New ETFs - GlobeNewswire
Will a $250 Million Buyback Amid Margin Pressures Shift the Hims & Hers (HIMS) Story? - simplywall.st
Why Hims & Hers Health Shares Are Sliding - TipRanks
Hims & Hers Health Stock (HIMS) Opinions on Q3 Earnings and Market Challenges - Quiver Quantitative
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
Hims Hers Health Inc Azioni (HIMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):